US FDA Allows Waiver Of Informed Consent For Clinical Investigations With Minimal Risk
Executive Summary
The agency seeks input on the types of qualifying investigations that involve minimal risk. Providing informed consent waivers in these cases, as required by the 21st Century Cures Act, will help advance health-care innovations, FDA says.